WORLD HEALTH ORGANIZATION ORGANISATION MONDIALE DE LA SANTÉ
REGIONAL OFFICE FOR EUROPE BUREAU RÉGIONAL DE L'EUROPE
WELTGESUNDHEITSORGANISATION ВСЕМИРНАЯ ОРГАНИЗАЦИЯ ЗДРАВООХРАНЕНИЯ
REGIONALBÜRO FÜR EUROPA ЕВРОПЕЙСКОЕ РЕГИОНАЛЬНОЕ БЮРО
A roadmap for infection prevention and /2
control guideline development and
implementation meeting
Nordic Hotel Forum 12 September 2019
Tallinn, Estonia
20-21 November 2019 Original: English
Scope and purpose
Background
According to WHO, defective infection prevention and control (IPC) practices during every day health
care delivery cause harm to hundreds of millions of patients worldwide every year. Health care-
associated infections (HAI) are among the most common complications of hospital stays including those
resistant to antimicrobials. No country or health system, even the most developed or sophisticated, can
claim to be free of HAIs.
Although significant progress has been made to reduce HAI in many parts of the world, a number of
emerging events have underlined the need to support countries in the development and strengthening of
IPC with the objective to achieve resilient health systems, both at the national and facility levels. In
recent years, the spread of Middle East respiratory syndrome coronavirus and the Ebola virus disease
outbreaks, revealed gaps in IPC measures applied by the countries concerned. Furthermore, the
International Health Regulations (IHR) and the Global Action Plan to combat antimicrobial resistance
(AMR) calls for strengthening IPC across nations.
In consideration of these factors, in 2016, WHO published the new guidelines on the core components of
IPC programmes with the aim to strengthen IPC capacities at national and facility levels. The guidelines
address eight areas (IPC programmes; Evidence Based Guidelines; Education and Training; Surveillance;
Multimodal Strategies; Monitoring, Audit and Feedback; Workload, Staffing and Bed Occupancy and the
Built Environment, Materials and Equipment) and comprise 11 recommendations and 3 Good Practice
Statements. The guidelines on the core components of IPC programmes form a key part of WHO
strategies to prevent current and future threats such as outbreaks of highly transmissible diseases
including Ebola and ultimately strengthen health service resilience through improving IPC capacities at
both national and facility levels.
WHO is actively supporting Members States in assessing their status with regard to IPC programme, and
necessary steps to be taken to fully implement the core components of IPC programmes at national and
facility levels.
WHO recommends that evidence-based guidelines should be developed and implemented for the purpose
of reducing HAI and AMR. The education and training of relevant health care workers on the guideline
recommendations and the monitoring of adherence with guideline recommendations should be
undertaken.
The WHO Guidelines on Core Components of Infection Prevention and Control Programmes at the
National and Acute Health Care Facility Level state: “The panel recommends that evidence-based
guidelines should be developed and implemented for the purpose of reducing HAI and AMR.”
The development of IPC guidelines, protocols and standard operating procedures and related
implementation strategies is a key function of national IPC programmes. Technical guidelines should
Scope and purpose
page 2
provide clear directions on IPC priorities, clear evidence-based standards and a framework for local
adaptation. Each country should establish when is the best time to develop IPC guidelines in the
implementation sequence of the core components’ recommendations. The availability of technical
guidelines on IPC programme organization and key IPC practices is usually a prerequisite for rolling out
IPC education and training, including IPC monitoring and evaluation, and these should adhere to IPC
principles and standards referred to in national guidelines.
With the aim to achieve successful implementation of the core components of IPC programmes, WHO is
committed to assist countries with the development of evidence-based IPC guidelines by designing a five
steps road map to maximize the likelihood of success and overcome some of the complexity of the
process.
This meeting is designed to explore, review and describe countries’ experiences with regards to the key
steps taken in the guideline development process.
Objectives
The objectives of the meeting are to:
- To explore the steps undertaken at national level for guideline development, adaptation and
implementation, based on the WHO IPC core components implementation manual
recommendations and the WHO guideline development handbook.
- To review and verify targeted steps for ‘preparing for action’ and ‘baseline assessment’.
- To describe countries’ experiences with regards to the key steps taken in the guideline
development.
- To explore the format for an easy to read roadmap for use at national level alongside other key
guidance documents.
Saatja: COUTINHO REHSE, Ana Paula <
[email protected]>
Saadetud: 04.10.2019 13:24
Adressaat: Elen Ohov <
[email protected]>
Koopia: Triin Uusberg <
[email protected]>; SM Info <
[email protected]>;
<
[email protected]>; <
[email protected]>; REINAP, Marge <
[email protected]>;
SIRK, Gerli <
[email protected]>
Teema: Nomination for infection prevention and control meeting, Tallinn, Estonia, 20-21
November 2019 - EST
Manused: ScopeAndPurpose_E.PDF; Nomin_lett_EST_021019.pdf
Dear Ms Elen Ohov
A roadmap for infection prevention and control guideline development and implementation meeting,
Tallinn, Estonia, 20-21 November 2019
I have a pleasure of sending you an invitation to the above-mentioned meeting that will take place in
Tallinn, Estonia, 20-21 November 2019.
An outline of the scope and purpose attached for your reference.
You are kindly asked to nominate one participant representing the National Infection Prevention and
Control programme. More detailed information regarding requirements to the participant is presented
in the letter attached.
We look forward to receiving your nomination, giving the name, functional title and address of the
proposed participant at your earliest convenience and no later than 22 October 2019.
Thank you for your feedback.
Best regards,
Ana Paula
Ms Ana Paula Coutinho Rehse
Technical Officer – Infection Prevention and Control
Infectious Hazard Management, Health Emergencies Programme
Division of Health Emergencies and Communicable Diseases
WHO Regional Office for Europe
Phone: +45 45 33 67 10,
Mob : +45 23 72 90 72
e-mail:
[email protected]